Smarter Decisions,
Better Care
UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point of care decisions.
For more information, click below.
Subscribers log in here
Related articles
| AuthorsMichael S Kiernan, MDJames E Udelson, MD, FACCMark Sarnak, MDMarvin Konstam, MD | Section EditorStephen S Gottlieb, MD | Deputy EditorSusan B Yeon, MD, JD, FACC |
Topic Outline
DEFINITION AND CLASSIFICATION
There are a number of important interactions between heart disease and kidney disease. The interaction is bidirectional as acute or chronic dysfunction of the heart or kidneys can induce acute or chronic dysfunction in the other organ. The clinical importance of such relationships is illustrated by the following observations:
The term cardiorenal syndrome (CRS) has been applied to these interactions, but the definition and classification have not been clear. A 2004 report from the National Heart, Lung, and Blood Institute defined CRS as a condition in which therapy to relieve congestive symptoms of HF is limited by a decline in renal function as manifested by a reduction in GFR [3]. The reduction in GFR was initially thought to result from a reduction in renal blood flow. However, various studies have demonstrated that cardiorenal interactions occur in both directions and in a variety of clinical settings [4]. (See 'Pathophysiology' below.)
The different interactions that can occur led to the following classification of CRS that was proposed by Ronco and colleagues [5]:
Subscribers log in here